Viper Networks and Apollo Metro Received Product Certification and Approval for the Eastern Province Municipalities in the Kingdom of Saudi Arabia

TROY, Mich., June 25, 2015 (GLOBE NEWSWIRE) -- Viper Networks, Inc. (Pink Sheets: VPER), is pleased to announce that the Company (in partnership with Apollo Metro Solutions, Inc.) has received a product certification and approval for the eastern province municipalities in the Kingdom of Saudi Arabia.

The Kingdom of Saudi Arabia has 13 provinces in total and we will be focusing on getting the certification for all of them in the next few months. Saudi Arabia has the largest market in the Middle East for LED street lights as it is projected to grow up to 25 Billion USD in the next decade.

Part of the certification was the Intelligent LED Lighting technology and Wireless Street Light Control for LED Street Lights as this is the new trend of the Smart Streetlights for the future.

The pilot programs in Lebanon is at final stage and we expect the engineering team to collect all data and measurements by the end of July, after that we will certify the product for all municipalities.

For more information please visit the Company's products and services at www.ViperNetworks.com or www.ApolloMetro.com.

Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate.

CONTACT: Investor Relations:
         Heritage First Capital
         Scott Gibson
         407.444.5959

You May Also Be Interested In

• PEP-Therapy and Institut Curie Announce First Patients Dosed in Phase Ib Clinical Trial Evaluating PEP-010 in Ovarian and Pancreatic Cancers
• Uxin Reports Unaudited Third Quarter of Fiscal Year 2024 Financial Results
• Net Asset Value(s)